Atrial fibrillation-related complications following short-term use of antibiotics in patients receiving NOAC or warfarin

2 September 2024 (12:00 - 12:50)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Miss Jiayi Huang

The University of Hong Kong, Hong Kong (Hong Kong)

8 More presentations in this session

Presentation thumbnail

Switching from warfarin to a DOAC in frail elderly asian patients with atrial fibrillation: a nationwide population-based study

Doctor Y. Go (Seoul, KR)

Abstract Slides Video

Presentation thumbnail

Drug interactions in incident NOACs users and risk of bleeding

Doctor M. Amadori (Bologna, IT)

Abstract Slides Video

Presentation thumbnail

Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

Doctor H. Shin (Busan, KR)

Abstract Slides Video

Presentation thumbnail

Resumption of anticoagulation therapy among Non-Valvular Atrial Fibrillation (NVAF) patients with prior intracranial haemorrhage

Doctor W. Sun (Shatin, HK)

Abstract Slides Video

Presentation thumbnail

Comparing the real-world and clinical trial bleeding rates associated with oral anticoagulation treatment for atrial fibrillation

Doctor Y. Gue (Liverpool, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Clinical decision-making about oral anticoagulant therapy in atrial fibrillation

The Event

Event poster

ESC Congress 2024

2 September 2024 12:00 CET

You may be interested in

Congress Session

Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations

Congress Presentation

Temporal trends of prescription rates, dosing of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation

Congress Presentation

Anticoagulation and stroke in hospitalized patients newly diagnosed with secondary atrial fibrillation: a population-based cohort study